In a decisive move to secure the pharmaceutical supply chain, the Federal Cabinet has approved the nationwide deployment of a digital Track and Trace System for all medicinal products. Announced by Federal Minister for National Health Services Mustafa Kamal, the initiative is designed to establish an ironclad barrier against the multi-billion-rupee market of counterfeit, fake, and substandard medicines that have long endangered lives across the country.

To legally back the digital rollout, the government has pushed through vital amendments to the Drug Labeling and Packing Rules, transitioning Pakistan’s pharmaceutical oversight from legacy paper trailing to a real-time digital infrastructure.

How the Digital Framework Operates

The Drug Regulatory Authority of Pakistan (DRAP) is spearheading the rollout, replacing easily manipulated conventional stamps with a modern data framework. Under the new guidelines, the entire lifecycle of a drug is monitored transparently:

• Serialization at the Source: Every pharmaceutical manufacturer and importer is now legally mandated to print unique, standardized 2D barcodes and serialization data directly onto medicine packaging.
• Regulator Oversight: DRAP and federal inspectors can trace batches instantaneously, monitoring inventory from the manufacturing plant floor, through wholesale distributors, down to individual pharmacy shelves.
• Consumer Empowerment: Once the system is fully active, everyday citizens can use their smartphones to scan medicine boxes before purchasing. The system instantly verifies the retail price, exact expiry date, and authentic certification status.

Countering a Silent Crisis

The scale of the counterfeit medicine issue in Pakistan has historically burdened both public health and economic revenues. The adoption of this tracking infrastructure brings the nation’s drug enforcement laws up to modern regional standards.

Phase Status	Target Stakeholders	Primary Objective
Cabinet Approved	Drug Regulatory Authority (DRAP)	Drafting detailed technical compliance codes and onboarding domestic manufacturers.
Industry Onboarding	Importers & Local Pharma Plants	Calibrating packaging lines to incorporate standardized 2D data matrices.
Public Launch	Retailing Pharmacies & Consumers	Activating consumer-facing verification applications and ending unauthorized price hikes.

While consultative sessions have already concluded with manufacturing groups to ensure a smooth technical transition, DRAP will soon publish explicit timeline windows for when un-barcoded inventory will be systematically barred from retail sales.